When should a skin substitute be applied to a surgical wound?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: November 17, 2026 • View editorial policy

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.

When to Use Skin Substitutes on Surgical Wounds

Skin substitutes should generally NOT be used routinely on surgical wounds, with the primary exception being post-surgical diabetic foot wounds where standard care has failed, and only when resources and expertise are available. 111

Primary Recommendations Based on Wound Type

Post-Surgical Diabetic Foot Wounds

  • Consider negative pressure wound therapy (NPWT) as the preferred adjunctive treatment for post-surgical diabetes-related foot wounds 1
  • Do NOT use cellular skin substitutes as routine adjunct therapy (conditional recommendation, low-quality evidence) 11
  • Do NOT use acellular skin substitutes as routine adjunct therapy (conditional recommendation, low-quality evidence) 11
  • Do NOT use autologous skin graft substitutes (strong recommendation against) 11

Key caveat: While some evidence suggests skin substitutes may improve healing rates, all studies had high risk of bias due to non-blinding, high dropout rates, and per-protocol analyses rather than intention-to-treat. The moderate costs and resources required make cost-effectiveness unlikely compared to standard care. 11

Deep Burns in Functional/Mobile Areas

Consider dermal substitutes in the acute phase (within 3-21 days of injury) for:

  • Deep partial or full-thickness burns
  • Functional anatomic areas: face, neck, axilla, elbow, popliteal regions
  • Wounds >10 cm² requiring contracture prevention

Approach by depth:

  • One-stage approach: Deep dermal to full-thickness wounds >10 cm² 2
  • Two-stage approach: Same depth wounds with limited donor sites OR exposed bone/tendon 2
    • Apply dermal substitute after surgical debridement
    • Follow with autologous split-thickness skin graft after 14-21 days 3

Contraindications:

  • Active wound infection 2
  • Allergies to matrix components 2
  • Electrical or chemical burns (use with extreme caution) 2

Non-Surgical Chronic Wounds

Do NOT use skin substitutes for non-surgical diabetic foot ulcers - insufficient evidence exists to support this practice 44

Alternative Treatments to Consider First

Before considering skin substitutes, optimize standard care:

  1. For diabetic foot ulcers with inadequate healing after 2+ weeks:

    • Sucrose-octasulfate impregnated dressing (non-infected, neuro-ischemic ulcers) 11
    • Autologous leucocyte, platelet, and fibrin patch (where standard care failed and venepuncture resources exist) 11
    • Placental-derived products (where standard care failed) 11
  2. For venous leg ulcers:

    • Growth factors (EGF, FGF, GM-CSF) or PRP for granulation tissue formation 5
    • NPWT for refractory cases, particularly with instillation and dwell time (NPWTi-d) 5

Critical Implementation Points

When skin substitutes ARE used:

  • Secure with suture, adhesive strips, and/or secondary dressing 11
  • Requires specialized expertise and organization 4
  • Monitor for adverse effects: wound maceration, dressing retention, infection 44
  • Expect stimulation of healing process but NOT complete epithelialization 4

Common pitfall: The evidence base is plagued by heterogeneous products, inconsistent blinding, high dropout rates, and publication bias. Do not assume all skin substitutes are equivalent or effective. 11

Bottom Line Algorithm

  1. Is this a post-surgical diabetic foot wound? → Try NPWT first 1
  2. Is this an acute deep burn in a functional area? → Consider dermal substitute if >10 cm² 23
  3. Is this any other surgical wound? → Use standard wound care; skin substitutes not recommended 11
  4. Has standard care failed for 2+ weeks? → Consider specific alternatives (sucrose-octasulfate, autologous platelet products, placental products) before skin substitutes 11

The overarching principle: skin substitutes are expensive, require expertise, and lack robust evidence for routine use in most surgical wounds. Standard wound care with appropriate debridement, infection control, and offloading remains the foundation of treatment.

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.